Taxotere (docetaxel) supply shortage
Taxotere is used to treat the following cancers: breast cancer, non-small-cell lung, prostate cancer, gastric adenocarcinoma (a type of stomach cancer), and head and neck cancer. Reason for shortage A failure in the filling process at a manufacturing site in Germany has led to Taxotere vials being up to 5 % over-concentrated. The vials contain the same total amount of active substance but in a smaller volume. Sanofi on behalf of the marketing authorisation holder for Taxotere, has therefore initiated a recall of affected batches.
Click on this link for more information.
